Rigel Pharmaceuticals (RIGL) Amortizatization of Intangibles (2017 - 2025)
Rigel Pharmaceuticals has reported Amortizatization of Intangibles over the past 9 years, most recently at $243000.0 for Q4 2025.
- For Q4 2025, Amortizatization of Intangibles fell 11.96% year-over-year to $243000.0; the TTM value through Dec 2025 reached $1.2 million, up 62.2%, while the annual FY2025 figure was $1.2 million, 62.2% up from the prior year.
- Amortizatization of Intangibles for Q4 2025 was $243000.0 at Rigel Pharmaceuticals, down from $467000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $467000.0 in Q3 2025 and troughed at -$116000.0 in Q4 2021.
- A 5-year average of $105700.0 and a median of $87000.0 in 2023 define the central range for Amortizatization of Intangibles.
- Biggest five-year swings in Amortizatization of Intangibles: plummeted 690.0% in 2022 and later skyrocketed 1266.67% in 2023.
- Year by year, Amortizatization of Intangibles stood at -$116000.0 in 2021, then soared by 254.31% to $179000.0 in 2022, then surged by 45.25% to $260000.0 in 2023, then rose by 6.15% to $276000.0 in 2024, then dropped by 11.96% to $243000.0 in 2025.
- Business Quant data shows Amortizatization of Intangibles for RIGL at $243000.0 in Q4 2025, $467000.0 in Q3 2025, and $250000.0 in Q2 2025.